FDA Approves Qfitlia: A Breakthrough Treatment Revolutionizing Hemophilia Care
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced the approval of Qfitlia (fitusiran), a treatment designed to prevent or reduce the frequency of bleeding episodes in …
FDA Approves Qfitlia: A Breakthrough Treatment Revolutionizing Hemophilia Care Read More